Bilim Pharmaceuticals:企業の戦略的SWOT分析

GlobalDataが発行した調査報告書(GDPH128454SA)
◆英語タイトル:Bilim Pharmaceuticals - Strategic SWOT Analysis Review
◆商品コード:GDPH128454SA
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年1月25日
◆ページ数:20
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:トルコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Bilim Pharmaceuticals – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Bilim Pharmaceuticals (Bilim) is a pharmaceutical company that develops, manufactures and markets generic pharmaceutical products. The company manufactures products for the treatment of conditions related to cardiovascular system, dermatology, urology, gynecology, musculoskeletal system, nervous system, and respiratory system, among others. Its products include Acnemix, Apirex, Alzant, Beklazon, Bacoderm, A-Ferin, Elynza, Eksofed, Hyalgan, Momecon, Neurovit, Norsol, Paden, Panizaro, Gayaban and Gentagut, among others. Bilim has production plants in Gebze and Cerkezkoy and also operates a research and development center. Bilim has offices in Moldova, Georgia, Bosnia-Herzegovina and Albania.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
Section 1 – About the Company 4
Bilim Pharmaceuticals – Key Facts 4
Bilim Pharmaceuticals – Key Employees 5
Bilim Pharmaceuticals – Major Products and Services 6
Bilim Pharmaceuticals – History 7
Bilim Pharmaceuticals – Company Statement 9
Bilim Pharmaceuticals – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Bilim Pharmaceuticals – Key Manufacturing Facilities 12
Section 2 – Company Analysis 13
Bilim Pharmaceuticals – Business Description 13
Bilim Pharmaceuticals – Corporate Strategy 14
Bilim Pharmaceuticals – SWOT Analysis 15
SWOT Analysis – Overview 15
Bilim Pharmaceuticals – Strengths 15
Strength – R&D Competence 15
Strength – Strong Market Position 15
Strength – Production Capabilities 15
Bilim Pharmaceuticals – Weaknesses 16
Weakness – Product recalls 16
Bilim Pharmaceuticals – Opportunities 17
Opportunity – Market Potential -Musculoskeletal Disorder Therapy 17
Opportunity – Market Potential – CNS Therapy 17
Opportunity – Demographic Trends 17
Bilim Pharmaceuticals – Threats 18
Threat – Competitive Landscape 18
Threat – Growing Parallel Trade 18
Threat – Increased Drug Scrutiny 18
Bilim Pharmaceuticals – Key Competitors 19
Section 3 – Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Bilim Pharmaceuticals, Key Facts 4
Bilim Pharmaceuticals, Key Employees 5
Bilim Pharmaceuticals, Major Products and Services 6
Bilim Pharmaceuticals, History 7
Bilim Pharmaceuticals, Other Locations 10
Bilim Pharmaceuticals, Key Manufacturing Facilities 12
Bilim Pharmaceuticals, Key Competitors 19

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Bilim Pharmaceuticals:企業の戦略的SWOT分析(Bilim Pharmaceuticals - Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆